bioRxivImmunologyPreprint
High-Dimensional Imaging of Vestibular Schwannoma Reveals Distinctive Immunological Networks Across Histomorphic Niches in NF2-related Schwannomatosis
A. P. Jones, M. J. Haley, G. E. Gregory, C. J. Hannan, A. K. Simmons, L. D. Bere, D. G. Lewis, P. Oliveira, M. J. Smith, A. T. King, D. G. Evans, P. Paszek, D. Brough, O. N. Pathmanaban, K. Couper
Abstract
NF2-related Schwannomatosis (NF2 SWN) is a rare tumour-predisposition syndrome characterised by the growth of multiple central and peripheral nervous system neoplasms. The drivers of NF2 SWN are pathogenic variants in the tumour suppressor gene NF2, encoding the protein Merlin, leading to development of bilateral vestibular schwannoma (VS) in >95% of patients. VS tumours are characterised by infiltration of myeloid cells and lymphocytes, highlighting the potential of immunotherapy for VS. However, the immunological landscape in VS and the spatial determinants within the tumour microenvironment that shape the trajectory of disease are presently unknown. In this study, to elucidate the complex immunological networks across VS, we performed imaging mass cytometry (IMC) on clinically annotated VS samples from NF2 SWN patients. We reveal the heterogeneity in neoplastic cell, myeloid cell and T cell populations that co-exist within VS, determining that the cellular composition of VS tumours is independent of NF2-SWN genetic severity. We show that distinct myeloid cell and Schwann cell populations exist within varied spatial contextures across characteristic Antoni A and B histomorphic niches. Interestingly, we show that T-cell populations associate with tumour-associated macrophages (TAMs) in Antoni A regions, seemingly limiting their ability to interact with tumorigenic Schwann cells. This spatial landscape is altered in Antoni B regions, where T-cell populations appear to interact with PD-L1+ Schwann cells. We also demonstrate that prior bevacizumab treatment (VEGF-A antagonist) preferentially reduces alternatively-activated TAMs, whilst enhancing CD44 expression, in bevacizumab-treated tumours. Together, we describe niche-dependent modes of T-cell regulation in NF2 SWN VS, indicating the potential for microenvironment-altering therapies for VS. TeaserImaging mass cytometry and spatial omic analyses illustrate spatially-distinct regions of T-cell regulation in vestibular schwannoma.
- organism: human
- assay: spatial transcriptomics
- research focus: cell-cell communication
- research focus: spatial domain detection
- approach: microscopy & imaging analysis
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma Model
Simeng Lu, Zhenzhen Yin, … Lei Xu·Nature CommunicationsPeer-reviewed·Feb 11, 2026
- Direct and abscopal anti-tumor responses elicited by peripheral nerve schwannoma irradiation synergize with anti-PD1 treatment in vestibular schwannoma models
Zhenzhen Yin, Simeng Lu, … Lei Xu·bioRxiv·Dec 29, 2024
- Cellular mechanisms of heterogeneity in NF2-mutant schwannoma
C. C. MacKenzie, J. Vitte, … A. I. McClatchey·bioRxiv·Dec 31, 2020
- Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas.
Maxwell Thomas Laws, Dhruval Bhatt, … Prashant Chittiboina·bioRxiv·Nov 15, 2025
- Single-cell multi-omic analysis of the vestibular schwannoma ecosystem uncovers a nerve injury-like state
T. F. Barrett, B. Patel, … A. H. Kim·bioRxiv·Nov 18, 2022
- Quantitative imaging of schwannoma captures heterogeneity and accelerates preclinical testing, exposing distinct therapeutic signatures
Emily Wright, Jérémie Vitte, … Andrea I. McClatchey·bioRxiv·Sep 30, 2026